Role of phenmetrazine as an active metabolite of phendimetrazine: Evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys

Drug and Alcohol Dependence

Volumn 130, Issue 1-3, 2013, Pages 158-166

  Banks, Matthew L ^a   Blough, Bruce E ^b   Fennell, Timothy R ^b   Snyder, Rodney W ^b   Negus, S Stevens ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Addiction; Cocaine; Discrimination; Pharmacokinetic; Phendimetrazine; Phenmetrazine; Rhesus monkey

Indexed keywords

COCAINE; DRUG METABOLITE; PHENDIMETRAZINE; PHENMETRAZINE; SODIUM CHLORIDE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISCRIMINATION; DRUG POTENCY; ISOMER; MALE; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RHESUS MONKEY;

ANIMALS; COCAINE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; MACACA MULATTA; MALE; MORPHOLINES; PHENMETRAZINE; REACTION TIME;

MACACA MULATTA;

EID: 84877073499     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.10.026     Document Type: Article

References (35)

1. Balster R.L., Schuster C.R. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J. Exp. Anal. Behav. 1973, 20:119-129.
2. Banks M.L., Blough B.E., Negus S.S. Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys. Neuropsychopharmacology 2012, 10.1038/npp.2012.193.
3. Banks M.L., Blough B.E., Negus S.S. Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys. Behav. Pharmacol. 2011, 22:824-836.
4. Beardsley P.M., Sokoloff P., Balster R.L., Schwartz J.C. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and d-amphetamine and is not self-administered. Behav. Pharmacol. 2001, 12:1-11.
5. Beckett A.H., Salami M.A. A note on the identification of N-hydroxyphenmetrazine as a metabolic product of phendimetrazine and phenmetrazine. J. Pharm. Pharmacol. 1972, 24:900-902.
6. Chait L.D., Uhlenhuth E.H., Johanson C.E. The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology (Berl) 1986, 89:301-306.
7. Chait L.D., Uhlenhuth E.H., Johanson C.E. Reinforcing and subjective effects of several anorectics in normal human volunteers. J. Pharmacol. Exp. Ther. 1987, 242:777-783.
8. Chiodo K., Lack C., Roberts D. Cocaine self-administration reinforced on a progressive ratio schedule decreases with continous d-amphetamine treatment in rats. Psychopharmacology 2008, 200:465-473.
9. Corwin R.L., Woolverton W.L., Schuster C.R., Johanson C.E. Anorectics: effects on food intake and self-administration in rhesus monkeys. Alcohol Drug Res. 1987, 7:351-361.
10. Czoty P.W., Gould R.W., Martelle J.L., Nader M.A. Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology 2011, 36:539-547.
11. de la Garza R., Johanson C.E. Discriminative stimulus properties of cocaine in pigeons. Psychopharmacology (Berl) 1985, 85:23-30.
12. de la Garza R., Johanson C.E. Discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. J. Pharmacol. Exp. Ther. 1987, 243:955-962.
13. Evans S.M., Johanson C.E. Amphetamine-like effects of anorectics and related compounds in pigeons. J. Pharmacol. Exp. Ther. 1987, 241:817-825.
14. Gold L.H., Balster R.L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berl) 1996, 126:286-292.
15. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., Moeller F.G. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J. Clin. Psychopharmacol. 2001, 21:522-526.
16. Grabowski J., Rhoades H., Stotts A., Cowan K., Kopecky C., Dougherty A., Moeller F.G., Hassan S., Schmitz J. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 2004, 29:969-981.
17. Grabowski J., Shearer J., Merrill J., Negus S.S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict. Behav. 2004, 29:1439-1464.
18. Greenwald M.K., Lundahl L.H., Steinmiller CL Sustained release d-amphetamine reduces cocaine but not " Speedball" -seeking in buprenorphine-maintained volunteers. A test of dual-agonist pharmacotherapy for cocaine/heroin polydrug users. Neuropsychopharmacology 2010, 35:2624-2637.
19. Griffiths R.R., Brady J.V., Bradford L.D. Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. Advances in Behavioral Pharmacology 1979, 164-208. Academic Press, New York. T. Thompson, P.B. Dews (Eds.).
20. Griffiths R.R., Winger G., Brady J.V., Snell J.D. Comparison of behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology (Berl) 1976, 50:251-258.
21. Herin D.V., Rush C.R., Grabowski J. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann. N.Y. Acad. Sci. 2010, 1187:76-100.
22. Huttunen K.M., Raunio H., Rautio J. Prodrugs-from serendipity to rational design. Pharmacol. Rev. 2011, 63:750-771.
23. Kampman K.M. What's new in the treatment of cocaine addiction?. Curr. Psychiatry Rep. 2010, 12:441-447.
24. Kreek M.J., LaForge K.S., Butelman E. Pharmacotherapy of addictions. Nat. Rev. Drug Discov. 2002, 1:710-726.
25. Lamas X., Negus S.S., Hall E., Mello N.K. Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys. Psychopharmacology (Berl) 1995, 121:331-338.
26. Negus SS Rapid assessment of choice between cocaine and food in rhesus monkeys: Effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 2003, 28:919-931.
27. Negus S.S., Baumann M.H., Rothman R.B., Mello N.K., Blough B.E. Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J. Pharmacol. Exp. Ther. 2009, 329:272-281.
28. Nyswander M. The Drug Addict as a Patient 1956, Grune and Stratton, New York.
29. Oliveto A.H., McCance-Katz E., Singha A., Hameedi F., Kosten T.R. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav. Pharmacol. 1998, 9:207-217.
30. Rothman R.B., Blough B.E., Woolverton W.L., Anderson K.G., Negus S.S., Mello N.K., Roth B.L., Baumann M.H. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J. Pharmacol. Exp. Ther. 2005, 313:1361-1369.
31. Rothman R.B., Katsnelson M., Vu N., Partilla J.S., Dersch C.M., Blough B.E., Baumann M.H. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain. Eur. J. Pharmacol. 2002, 447:51-57.
32. Schindler C.W., Panlilio L.V., Thorndike E.B. Effect of rate of delivery of intravenous cocaine on self-administration in rats. Pharmacol. Biochem. Behav. 2009, 93:375-381.
33. Shearer J., Wodak A., Van Beek I., Mattick R.P., Lewis J. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 2003, 98:1137-1141.
34. Vocci F., Ling W. Medications development: successes and challenges. Pharmacol. Ther. 2005, 108:94-108.
35. Wood D.M., Emmett-Oglesby M.W. Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine. Psychopharmacology (Berl) 1988, 95:364-368.